Follow
Seema Agarwal
Seema Agarwal
Associate Professor, Department of Pathology, Georgetown University
Verified email at georgetown.edu
Title
Cited by
Cited by
Year
Subcellular localization of the yeast proteome
A Kumar, S Agarwal, JA Heyman, S Matson, M Heidtman, S Piccirillo, ...
Genes & development 16 (6), 707-719, 2002
8852002
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
6662010
Large-scale analysis of the yeast genome by transposon tagging and gene disruption
P Ross-Macdonald, PSR Coelho, T Roemer, S Agarwal, A Kumar, ...
Nature 402 (6760), 413-418, 1999
6611999
Zip3 provides a link between recombination enzymes and synaptonemal complex proteins
S Agarwal, GS Roeder
Cell 102 (2), 245-255, 2000
3322000
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
X Liu, E Krawczyk, FA Suprynowicz, N Palechor-Ceron, H Yuan, A Dakic, ...
Nature protocols 12 (2), 439-451, 2017
2102017
Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product
G Kaur, M Hollingshead, S Holbeck, V Schauer-Vukašinović, RF Camalier, ...
Biochemical Journal 396 (2), 235-242, 2006
1832006
Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells
J Kato-Stankiewicz, I Hakimi, G Zhi, J Zhang, I Serebriiskii, L Guo, ...
Proceedings of the National Academy of Sciences 99 (22), 14398-14403, 2002
1812002
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis
V Neumeister, S Agarwal, J Bordeaux, RL Camp, DL Rimm
The American journal of pathology 176 (5), 2131-2138, 2010
1662010
miR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer
BD Adams, VB Wali, CJ Cheng, S Inukai, CJ Booth, S Agarwal, DL Rimm, ...
Cancer research 76 (4), 927-939, 2016
1292016
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells
S Agarwal, C Zerillo, J Kolmakova, JG Christensen, LN Harris, DL Rimm, ...
British journal of cancer 100 (6), 941-949, 2009
1072009
Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma
BR Correa, PR de Araujo, M Qiao, SC Burns, C Chen, R Schlegel, ...
Genome biology 17 (1), 125, 2016
792016
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
JA Hanna, H Wimberly, S Kumar, F Slack, S Agarwal, DL Rimm
Biotechniques 52 (4), 235-245, 2012
722012
In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA
JA Hanna, L Hahn, S Agarwal, DL Rimm
Laboratory investigation 92 (10), 1390-1397, 2012
702012
Design and modular parallel synthesis of a MCR derived α-helix mimetic protein–protein interaction inhibitor scaffold
W Antuch, S Menon, QZ Chen, Y Lu, S Sakamuri, B Beck, ...
Bioorganic & medicinal chemistry letters 16 (6), 1740-1743, 2006
662006
Pyridinium chlorochromate: an improved method for its synthesis and use of anhydrous acetic acid as catalyst for oxidation reactions
S Agarwal, HP Tiwari, JP Sharma
Tetrahedron 46 (12), 4417-4420, 1990
661990
Quantitative assessment of invasive mena isoforms (Mena calc) as an independent prognostic marker in breast cancer
S Agarwal, FB Gertler, M Balsamo, JS Condeelis, RL Camp, X Xue, J Lin, ...
Breast Cancer Research 14 (5), 1-8, 2012
542012
Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer
A Dimou, V Neumeister, S Agarwal, V Anagnostou, K Syrigos, DL Rimm
The American journal of pathology 181 (4), 1436-1442, 2012
482012
Zebrafish Xenografts for Drug Discovery and Personalized Medicine
J Xiao, E Glasgow, S Agarwal
Trends in Cancer, 2020
452020
A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug
C Chen, S Choudhury, D Wangsa, CJ Lescott, DJ Wilkins, P Sripadhan, ...
Scientific reports 7 (1), 1-15, 2017
442017
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
N Palechor-Ceron, E Krawczyk, A Dakic, V Simic, H Yuan, J Blancato, ...
Cells 8 (11), 1327, 2019
382019
The system can't perform the operation now. Try again later.
Articles 1–20